Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid

Archives of Dermatology

Volumn 133, Issue 6, 1997, Pages 719-724

  Joly, Pascal ^a   Gilbert, Danièle ^a   Thomine, Elisabeth ^a   Delpech, Annie ^a   Courville, Philippe ^a   Young, Paul ^a   Le Corvaisier, Christine ^a   Lauret, Philippe ^a   Tron, François ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASEMENT MEMBRANE ANTIBODY;

ANTIBODY LABELING; ANTIGEN SPECIFICITY; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PEMPHIGOID; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0030903577     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.6.719     Document Type: Article

References (44)

1. Lever WF. Pemphigus and Bullous Pemphigoid. Springfield, III: Charles C Thomas Publisher; 1965:16-118.
2. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell. 1981;24:897-903.
3. Stanley JR. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated disease. J Clin Invest. 1989;83:1443-1448.
4. Holubar K, Wolff K, Konrad K, Beutner EH. Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. J Invest Dermatol. 1975;64:220-227.
5. Yamasaki Y, Nishikawa T. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid. Acta Derm Venereol. 1983;63:501-506.
6. Mutasim DF, Takahashi Y, Labib RS, et al. A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol. 1085;84:47-53.
7. Regnier M, Vaigot P, Michel S, Prunieras M. Localization of bullous pemphigoid antigen (BPA) in isolated human keratinocytes. J Invest Dermatol. 1985; 85:187-190.
8. Mutasim DF, Morrisson LH, Takahashi Y, et al. Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol. 1989;92:225-230.
9. Shimizu H, Kayakawa K, Nishikawa T. A comparative immunoelectron microscopic study of typical and atypical cases of pemphigoid. Br J Dermatol. 1988; 119:717-722.
10. Westgate GE, Weaver AC, Couchman JR. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes. J Invest Dermatol. 1985;84:218-224.
11. Stanley JR, Woodley DT, Katz SI. Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol. 1984;82:108-111.
12. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986;136:1231-1235.
13. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D. Isolation of cDNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest. 1988;82:1864-1870.
14. Amagai M, Hashimoto T, Tajima S, et al. Partial cDNA cloning of the 230-kD mouse bullous pemphigoid antigen by use of a human monoclonal antibasement membrane zone antibody. J Invest Dermatol. 1990;95:252-259.
15. Sawamura D, Nomura K, Sugita Y, et al. Bullous pemphigoid antigen (BPAG1): cDNA cloning and mapping of the gene to the short arm of human chromosome 6. Genomics. 1990;8:722-726.
16. Sawamura D, Li K, Uitto J. 230-kD and 180-kD bullous pemphigoid antigens are distinct gene products. J Invest Dermatol. 1992;98:942-943.
17. Robledo MA, Kim SC, Korman NJ, et al. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. J Invest Dermatol. 1990;94:793-797.
18. Ishiko A, Shimizu H, Kikuchi A, Ebihara T, Hashimoto T, Nishikawa T. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosomes, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest. 1993;91:1608-1615.
19. Onodera Y, Shimizu H, Hashimoto T, et al. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin. J Invest Dermatol. 1994;102:686-690.
20. Korman NJ. In situ bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigen. J Invest Dermatol. 1995;105:824-830.
21. Anhalt GJ, Bahn CF, Labib RS, Voorhees JJ, Sugar A, Diaz LA. Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest. 1981;68:1097-1101.
22. Sams WM Jr, Gammon WR. Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol. 1982;6:431-449.
23. Naito K, Morioka S, Ogawa H. The pathogenic mechanisms of blister formation in bullous pemphigoid. J Invest Dermatol. 1982;79:303-306.
24. Liu Z, Diaz LA, Tor JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP 180. J Clin Invest. 1993;92:2480-2488.
25. Gammon WR, Briggaman RA, Inman AO III, et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol. 1984; 82:139-144.
26. Gammon WR, Kowalewski C, Chorzelski TP, Kumar V, Briggaman RA, Beutner EH. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol. 1990;22:664-670.
27. Gilbert D, Joly P, Thibout A, et al. Production of a human monoclonal anti-epithelial cell surface antibody from a patient with pemphigus vulgaris. J Autoimmun. 1992;5:173-182.
28. Joly P, Gilbert D, Thomine E, et al. Immunofluorescence and immunoelectron microscopy analyses of a human monoclonal anti-epithelial cell surface antibody that recognizes a 185-kD polypeptide: a component of the paraneoplastic pemphigus antigenic complex? J Invest Dermatol. 1993;101:339-345.
29. Prost C, Dubertret L, Fosse M, Wechsler J, Touraine R. A routine immunoelectron microscopic technique for localizing an autoantibody on epidermal basement membrane. Br J Dermatol. 1984;110:1-7.
30. Prost C, Labeille B, Chaussade V, Guillaume JC, Martin N, Dubertret L. Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a prospective study of IgG and C3 bound in vivo in 32 patients. J Invest Dermatol. 1987;89:567-573.
31. Bernard PH, Didierjean L, Denis F, Saurat JH, Bonnetblanc JM. Heterogeneous bullous pemphigoid antibodies: detection and characterization by immuno-blotting when absent by indirect immunofluorescence. J Invest Dermatol. 1989; 92:171-174.
32. Landry M, Sams WM Jr. Systemic lupus erythematosus: studies of the antibodies bound to skin. J Clin Invest. 1973;52:1871-1880.
33. Domloge-Hultsch N, Bisalbutra P, Gammon WR, Yancey KB. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin. J Am Acad Dermatol. 1991;24:946-951.
34. Woodley DT. Immunofluorescence on salt split skin for the diagnosis of epidermolysis bullosa acquisita. Arch Dermatol. 1990;126:229-231.
35. Schaumburg-Lever G, Rule A, Schmidt-Ulrich B, Lever WF. Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid, a preliminary report. J Invest Dermatol. 1975;64:47-49.
36. Holubar K, Wolff K, Konrad K, Beutner EH. Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. J Invest Dermatol. 1975;64:220-227.
37. Shimizu H, Kayakawa K, Nishikawa T. A comparative immunoelectron microscopic study of typical and atypical cases of pemphigoid. Br J Dermatol. 1988; 119:717-722.
38. Horiguchi Y, Imamura S. Discrepancy between the localization of in vivo bound immunoglobulins in the skin and in vitro binding sites of circulating anti-BMZ antibodies in bullous pemphigoid: immunoelectron microscopic studies. J Invest Dermatol. 1986;87:715-719.
39. Golan TD, Gharavi AE, Elkon KB. Penetration of autoantibodies into living epithelial cells. J Invest Dermatol. 1993;100:316-322.
40. Joly P, Thomine E, Gilbert D, et al. Overlapping distribution of autoantibody specificities between pemphigus vulgaris and paraneoplastic pemphigus. J Invest Dermatol. 1994;103:65-72.
41. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus, an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990; 323:1729-1735.
42. Sawamura D, Li K, Chu ML, Uitto J. Human bullous pemphigoid antigen (BPAG1) amino acid sequences deduced from cloned cDNA predict biologically important peptide segments and protein domains. J Biol Chem. 1991;226:17784-17790.
43. Patel HP, Diaz LA, Anhalt GJ, Labib RS, Takahashi Y. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol. 1984;83:409-415.
44. Yancey KB. Adhesion molecules, II: interaction of keratinocytes with epidermal basement membrane. J Invest Dermatol. 1995;104:1008-1014.